sunakiment   Click here for help

GtoPdb Ligand ID: 14699

Synonyms: AMG 104 | AMG104 | AZD-8630 | AZD8630
Immunopharmacology Ligand
Compound class: Antibody
Comment: Sunakiment (AMG 104, formerly AZD-8630) is an anti-thymic stromal lymphopoietin (TSLP) antigen-binding fragment (Fab) class antibody. It prevents TSLP interaction with its receptor, thereby blocking TSLP-mediated signalling responses. Peptide sequences for the heavy and light chain variable regoins of sunakiment match those of antibody A5 as claimed in patent US7982016 [1].
No information available.
Summary of Clinical Use Click here for help
Sunakiment was progressed to clinical studies as a potential inhalation therapy for moderate-to-severe asthma.
Clinical Trials
Clinical Trial ID Title Type Source Comment References
NCT05110976 A Study to Investigate the Safety, Tolerability and Effects of AZD8630 in Healthy Subjects and Subjects With Asthma on Inhaled Corticosteroids and Long-acting Beta-agonists Phase 1 Interventional AstraZeneca First-in-human study 2
NCT06529419 A Dose Range-Finding Study to Assess the Efficacy and Safety of Multiple Dose Levels of AZD8630 in Adults With Uncontrolled Asthma at Risk of Exacerbations Phase 2 Interventional AstraZeneca